Diabetic retinopathy
Conditions
Interventions
Treatment group:Conventional treatment with the addition of Tongluo Mingmu Capsules
Control group:Conventional treatment
Sponsors
Shijiazhuang Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years (inclusive); (2) Meet the diagnostic criteria for type 2 diabetic retinopathy with blood stasis obstructing the collaterals, and deficiency of both Qi and Yin; (3) Diagnosed by examination as non-proliferative diabetic retinopathy (NPDR) stages I-III; (4) Voluntarily participate, understand, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Self-reported history of retinal laser photocoagulation treatment or suitability for photocoagulation treatment; (2) Self-reported other eye diseases, such as glaucoma, non-diabetic retinopathy, uveitis, retinal detachment, optic nerve diseases, or high myopia; (3) Patients with cataracts and vision 2.0×ULN (upper limit of normal); (5) Allergic to the components of the investigational drug; (6) Pregnant women, women planning pregnancy, or women who are breastfeeding; (7) Participated in other clinical trials in the past three months; (8) Participants whom the investigator considers to have potential risks or other factors making them unsuitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in corrected vision from baseline after 24 weeks of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the Staging of DR Retinopathy;Changes in the number of retinal hemorrhages and microaneurysms compared to baseline;Changes in intraocular pressure; | — |
Countries
China
Contacts
Public ContactChunli Chen,Junhong Duan,Juan Wang
Shijiazhuang Hospital of Traditional Chinese Medicine
Outcome results
None listed